Non-Hodgkin's lymphomas are divided into B-and T-cell neoplasms. The existence and the clinical relevance of lymphomas derived from the third lymphocyte lineage, ie, natural killer (NK) cells are still controversial. NK cells are lymphocytes that mediate cytotoxicity without prior sensitization. NK cells also have phenotypic and genotypic characteristics: they express the NK-related antigen CD56, T-cell markers such as CD2 and CD7, but do not express CD5 and T-cell receptor (TCR) proteins, and their TCR locus is not rearranged. Therefore, if NK cell lymphomas exist, they should express some T-cell markers, but not cup or yS TCR proteins. Such lymphomas are actually called TCR silent peripheral T cell lymphomas (PTCL). To detect and characterize NK cell lymphomas, we investigated the immunophenotype and immunogenotype of 35 patients with TCR silent PTCL. The first group included 16 patients with a lymphoma of CD5-CD56+ phenotype, which is identical t o normal NK ARE CASES OF natural killer (NK) cell lymphomas have been reported but, so far, no definition has been widely accepted. The NK cell lineage of these tumors was suggested on the basis of the cytotoxic activity of lymphoma cells,' the presence of cytoplasmic azurophilic granules,' or more recently, the immunophenotypic and/or immunogenotypic features."s NK cells are bone marrow derived lymphocytes that mediate cytotoxicity without prior sensitization. NK cells can also be characterized by their immunophenotype. They express the NK cell-related CD56 antigen, and some T-cell markers such as CD2 and CD7, but not CDS.'.' In contrast to T cells, they do not express T-cell receptor (TCR) proteins and have a germline configuration of TCR genes6 NK cells do not express the T-cell specific CD3 complex, but recent studies demonstrated the presence of the CD3e chain in fetal' and activated adult NK cells.'" T lymphocytes are characterized by the expression of the TCR, which is a heterodimer of either a and /3 chains (ap-cells. These patients had either a nasallnasopharyngeal lymphoma (1 1 cases) or a lymphoma with predominant nonnasallnon-nodal initial involvement (five cases). Eight of the nine cases for which immunogenotypic data were available lacked clonal rearrangement of the TCR y genes. Thus, these tumors are likely t o be NK cell lymphomas. The second group of 15 cases had a CD5' phenotype (14 were CD56-, and 1 was CD56') and clonal rearrangement of TCR y genes, indicating that they were true PTCL with unproductive TCR rearrangement. The four remaining cases were CD5-CD56-lymphomas and disclosed either a clonal (two cases) or no clonal (two cases) rearrangements of the TCR y genes. TCR), or y and S chains (yS-TCR). T lymphocytes also express T-cell markers CD2, CD3, CDS, and CD7. Peripheral T-cell lymphomas (PTCL) are supposed to derive from postthymic T lymphocytes. Most of them have the phenotypic and genotypic features of a/3 lymphocytes.'' Recently, we described PTCL expressing yS-TCR, which often have a peculiar hepatosplenic presentation."." However 20% to 30% of so called PTCL expressing at least one of the T-cell markers CD2, CD3, CDS, and CD7 do not express either a/3 or yS TCR,"." and thus have been referred as TCR silent PTCL.
Our purpose was to describe the histology, phenotype, and genotype of putative NK cell lymphomas, and to investigate if they constitute a clinically relevant entity. According to the phenotype of the NK cell, if NK cell lymphomas exist, they should have been previously classified as TCR silent PTCL. Therefore, to determine the main characteristics of NK cell lymphomas, we investigated the clinical, phenotypic, and genotypic features of 35 TCR silent PTCL occurring in European and north African patients. Our results strongly suggest that most, if not all, CDS-CD56' silent PTCL belong to the NK cell lineage. Furthermore, it appears that these NK cell lymphomas display peculiar clinical features because they commonly have a nasaVnasopharyngea1 and/or hepatosplenic involvement.
MATERIALS AND METHODS
Patient selection. The diagnosis of TCR silent PTCL was based on histological and immunohistochemical data available on both fixed and frozen tissue sections. Lymphoblastic lymphomas were excluded from the study, as well as mycosis fungoides. All biopsy specimens had the morphology of lymphoma on hematoxylin-eosin stained sections. On frozen sections, lymphoma cells expressed at least one of the T-cell antigens CD2, CD3, CD5, and CD7, but were negative with both PFl and 6TCR-I antibodies. Lymphoma cells were not stained by CD20 on paraffin embedded samples, or by CD19, CD79a, andor CD22 on frozen samples. Thirty-five cases of such TCR silent PTCL were retrieved from the files of the Depart- The lymphoma cells, which infiltrate the sinusoids, are CD56 positive, while hepatocytes are negative. (B) CD5 staining: Lymphoma cells are CD5 negative, whereas a reactive small T lymphocyte, which acts as internal positive control, is CD5 positive. Tissue specimens. Fresh tissue specimens were obtained for diagnosis from a lymph node (16), the spleen (2), the bone marrow (2), the liver (l), the sinonasal tract (8), the pharynx (l), the palate (l), the skin (2), and the intestine (2). One portion was immediately snap frozen in liquid nitrogen for phenotypic and genotypic studies. The others were fixed in buffered formaldehyde or Bouin's fixative and paraffin embedded for histopathological observation.
NK cell lines. The two NK cell lines YT2C2" and YTIndi mediated non-major histocompatibility complex (MHC) restricted cytotoxicity. Their immunophenotype was studied by immunohistochemistry on smears. The locus of the TCR y chain was analyzed by polymerase chain reaction (PCR) after DNA extraction.
Histological studies. Paraffin-embedded tissue specimens were stained with hematoxylin-eosin, Giemsa, and Sirius red. Cytologic preparations, when available, were stained by May-GrunwaldGiemsa. Each case was independently examined by two pathologists. Lymphomas were classified according to the Working Formulation" and to the updated Kiel classification." The presence of angioinvasive features was carefully investigated.
Immunohisrochemical staining. Cryostat sections were evaluated for B-cell, T-cell, and NK-cell differentiation antigens using the alka- To avoid contamination by amplification products, they were first held at 50°C for 10 minutes to allow uracil DNA glycosylase (UDG) to destroy any dUTP containing amplified product that could have been carried over from previous reactions. This incubation was followed by a 10-minute denaturation at 94°C before cycling. Each cycle included a denaturation step (94°C for 1 minute), an annealing step (56°C for 1 minute). and an elongation step (72°C for 2 minutes). After 40 cycles, residual Uracil DNA glycosylase was inactivated by the addition of 50 p L of chloroform.
For denaturing gradient gel electrophoresis (DGGE) analysis, 30 pL of the PCR amplified products were run on a 6.5% poiyacrylamide gel containing a linear increasing 10% to 60% denaturing gradient (100% denaturant = 7 mmoVL urea and 40% vol/vol formamide) in TAE buffer (Tris base 40 mmol/L, Sodium acetate 20 mmoVL, Na2EDTA 1 mmoVL, pH = 7.4). During the run, the gels were immersed in TAE buffer held at 60°C in a gel apparatus, which fits 22 cm long gels (CBS Scientific Company, Prolabo, Paris). Gels were run at 150 V for 5 hours, stained with ethidium bromide, and photographed under ultraviolet (UV) illumination.
The multiplex PCR only amplifies rearranged TCRy genes. The highly heterogeneous PCR y products of polyclonal reactive T cells result in a smear on DGGE, whereas a clonal rearrangement of y genes results in one (monoallelic) or two (biallelic) bands on DGGE. Dilution of clonal DNA in lymph node polyclonal DNA has shown that the sensitivity of PCRy clonal rearrangement assay is l%, which is five to 10 times more sensitive than Southern blot.I4 Using this assay, a clonal rearrangement was detected in 27 of 30 peripheral T-cell lymphomas and in none of 15 Hodgkin's disease cases.I4
In four former cases of the series, genetic study was performed using Southern blot analysis with a CD probe, as previously reported.?'
RESULTS
All cases had the histology of lymphomas, and most of them were classified as pleomorphic medium and large cell lymphomas (26 cases). Lymphoma cells expressed at least one of the four T-cell markers CD2, CD3, CD5, or CD7, but neither OF1 nor 6TCR-I in frozen sections. These lymphomas were evaluated for their T or NK cell lineage. Therefore, we divided these lymphomas into four groups according to the expression of CD5 and CD56, and especially focused on those with CD5-CD56' phenotype, a pattern commonly observed in normal N K cells (Fig 1) .
CD5-CD56+ lymphomas. This group included 16
patients (Table l) . The mean age was 44.8 years (range, 17 to 67). Eleven patients had nasalhasopharyngeal lymphoma at presentation, four of whom also had hepatosplenic localization either at the time of the diagnosis or during the course of the disease. The other five patients had a predominant non-nasal/ non-nodal initial involvement (ie, skin, liver, and bone marrow). Only four of the 16 patients had a lymph node involvement, either initially or during disease progression. The 16 cases belonged to the pleomorphic medium and large cell subtype, and six cases had histological features of angioinvasion. Most of them were CD2' (14 of 16), CD7' (1 1 of 16), and CD4-/CD8-(9 of 11). All but one were negative with Leu4/CD3 in frozen sections, whereas cytoplasmic expression of CD3t was observed in 10 of the 13 cases with interpretable results on paraffin embedded sections (Fig 2) . A positive staining of lymphoma cells with anti-CD36 was detected in five of 12 cases. A granular staining with TIA-1 was present in virtually all tumor cells in 11 of 13 cases (Fig 3) . Examination of the smears available for patients no. 6,9, 14, and 16 showed azurophilic granules within lymphoma cells in three cases (no. 6, 9, and 14). DNA samples were available for nine of RG, presence of two faint bands (see text).
_ "
Angiocentric T-cell lymphoma according to the "REAL" classification."
these patients. No clonal rearrangement of the TCR y genes was detected in eight cases ( Table 1 and Fig 4) , whereas in case no. 3, a faint biallelic signal, contrasting with the large number of lymphoma cells, was disclosed in both nasal and splenic samples. The significance of this rearrangement will be discussed. CDS' CD56-lymphomas. This group included 14 patients. The mean age was 57 years (range, 23 to 74; Table   2 ). All but one (patient no. 22) of these patients had a lymph node involvement at presentation. Extended stage of disease was frequent at presentation with an involvement of the bone marrow (seven cases), skin (six cases), spleen (two cases), liver (two cases). The lymphomas were classified as pleomorphic medium and large cell (seven cases), lymphadenopathy immunoblastic like lymphoma (three cases), anaplastic large cell (one case), T-zone (one case), small lymphocytic (one case), and Lennert's type (one case). Four cases had histological features of angioinvasion. Most of CD5' CD56-lymphomas were positive for CD2 (1 3 of 14 cases) and CD4 ( I 1 of 13 cases), and were also CD3 positive (Leu4/CD3: 13 of 14 cases and polyclonal anti-CD3c 12 of 12 cases). In contrast, lymphoma cells were negative with TIA-I in IO of 11 cases. PCR analysis was performed in 10 cases and disclosed clonal rearrangements of TCR y genes in all of them (Table 2 and Fig 4) . The four remaining cases, which were previously studied with Southern blot. had a clonal rearrangement of TCR 0 genes.*'
CDS' CD56'
lymphomas. In one case, the lymphoma cells had a CD5' CD56' phenotype (Table 2 ). This 81-year-old woman presented with multiple peripheral lymphadenopathies. Lymphoma cells were CD2', CD3' (Leu4/CD3 and polyclonal anti-CD3e), CD7', CD4' but TIA-I -. PCR analysis disclosed a clonal rearrangement of the TCR y genes.
CDS-CD56-lymphomas. This group included four patients with lymphoma cells positive either for Leu4/CD3 (two cases) or CD2 (two cases) ( Table 2 ). The lymphomas were classified as pleomorphic medium and large cell (two cases), small lymphocytic (one case) and anaplastic large cell type (one case). They were negative for the B-cell antigens CD19, CD20, and HM57/CD79a. All had a germ line configuration of the Ig heavy chain genes (not shown). Using PCR analysis, two cases had no clonal rearrangement of the TCR y genes. The two remaining cases were intestine lymphomas and disclosed clonal rearrangements of their TCR y genes. One of them was negative for TIA-I and positive for the human intestinal T-cell marker HMLI/ CD107, the other one was TIA-I+ and HMLI/CD107-. N K cell lines. Immunohistochemistry with anti-CD36 (polyclonal) on smears of both NK cell lines (YT2C2 and YTindi) showed a strong cytoplasmic staining (Fig 2) . Both NK cell lines had no detectable clonal TCR y genes rearrangements with PCR analysis (Fig 4) .
DISCUSSION
We report the clinical, histological, immunophenotypic, and immunogenotypic data of 35 European and north African patients with so called "TCR silent PTCL." To detect NK cell lymphomas. we classified these lymphomas into four groups according to the expression of CD5 and CDS6. The immunohistochemical data were then compared with the immunogenotype and the clinical data.
The first group of lymphomas included 16 cases with a CD2' CDS-CD%' phenotype, similar to that of NK cells."' Interestingly, in most of the cases, the lymphoma cells were negative with the Leu4KD3 antibody, but positive with the polyclonal antLCD36 antibody. These findings must be paralleled with the recent demonstration of cytoplasmic CD36 protein in fetal NK cells" and in activated adult NK cells.'" Furthermore. the two NK cell lines that we investigated were EMILE ET AL also positive with CD36 polyclonal antibody on smears, whereas they were negative with Leu4KD3 monoclonal antibody. A similar CD%' and Leu4KD3-pattern has been recently reported in a NK cell proliferation,' and in sinonasal lymphomas." An explanation for this discordant CD%+ and Leu4/CD3-phenotype is that Leu4/CD3 antibody recognizes a conformational epitope of CD%, which is only present when this chain is associated with either CD36 or CD37 chain,'3 whereas the polyclonal CD36 antibody is directed against a synthetic peptide'" and may recognize isolated CD36 chain. It has been previously reported that the CD36 chain, which was detected in five of 12 cases of the present series, can be expressed in NK cells. 24 In all but two cases, lymphoma cells were stained by TIA-I, a monoclonal antibody recognizing a cytolytic granule associated protein of cytotoxic T cells and NK cells.'" Because these lymphomas did not have the phenotype of CD8' cup TCR' cytotoxic T cells, this finding further supports the NK lineage of these tumors.
In this group of CDS-CDS6' lymphomas, eight of the nine patients for which the PCR analysis was performed had no clonal rearrangement of the TCR y genes. Immunohistochemistry demonstrated that many tumor cells were present in each sample. Considering the 1% sensitivity of the PCR assay, we conclude that the lymphoma cells were truly unrearranged in these cases. The absence of a detectable clonal rearrangement in CDS-CD%' lymphomas contrasts with the demonstration of clonal rearrangements of the TCR y genes in all TCR silent PTCL with the CDS' phenotype. In the remaining CDS-CDS6' TCR silent case, two faint bands could be detected. It can be hypothesized that the presence of faint bands in two samples of this patient containing more than 80% tumor cells could be related to an oligoclonal Tcell reaction. Normal NK cells, as well as the two NK cell lines of the present study, do not have clonal rearrangements of their TCR y genes. Thus, CDS-CDS6' TCR silent PTCL bear the immunophenotypic and immunogenotypic features of NK cells and NK cell lines.
Several years ago, Weiss et alZs reported seven cases of PTCL with germline and y TCR genes using Southern blot analysis. Interestingly, these seven cases were CD5 negative, CD2 positive, and all but one were Leu4/CD3 negative. Four were nasalhasopharyngeal lymphomas and two others were also non-nodal. Although the expression of CD56 was not studied, it might be speculated that these cases, which had clinical and phenotypic features similar to those of the present study, were NK cell lymphomas. Recently, Suzumiya et a14 reported immunohistochemical and immunogenotypic data of nine cases of CD%' nasahasopharyngeal lymphomas. Although the expression of TCR and CD5 was not studied. eight of nine were considered as NK cell lymphomas, because they had germline TCR genes on Southern blot analysis. Thus, despite the low number of cases described in the literature, there is a good correlation between CDS-CDS6' phenotype and the germline TCR genotype. Together, these features could be used to define NK cell lymphomas.
The 16 patients with CDS-CD56' lymphomas had a peculiar clinical presentation. Indeed, 11 patients had nasal/ In contrast, CD5+ CD56-TCR silent lymphomas strongly nasopharyngeal tumors and the remaining five patients had differ from the NK-cell group in view of their phenotypic a predominant non-nasdnon-nodal with hepatosplenic and and genotypic features and can be regarded as true PTCL. bone marrow or skin involvement. Furthermore, during the Indeed, most of them expressed the CD3c associated with disease progression, only four of the 16 patients presented y or 6 chain (LeU4/CD3 positive), had a helper phenotype, a lymph node involvement. This low incidence of lymph and all of them disclosed clonal rearrangements of the TCR node involvement was also observed by Weiss et a l Z 5 and genes. In addition, most of them were TIA-1 negative. ConSuzumiya et al? and contrasts with the usual disease presen-trasting with patients with NK cell lymphoma, all patients tation of B-and T-cell lymphomas in patients without preexbut one had a lymph node involvement at initial presentation. isting immunodeficiency. The most frequent involved sites, The absence of TCR protein expression in these PTCL may initially and/or during disease progression, were nasopharbe due either to a nonproductive rearrangement of TCR ynx, liver, spleen, bone marrow, and skin. This is consistent genes, or to a posttranscriptional defect of the TCR expreswith the results of previous studies, based on immunophenosion due to the neoplastic transformation. Interestingly, many type, showing two types of CD56+ lymphomas. Nasdnasoof these true PTCL did not express CD34. As CD35 knock pharyngeal lymphomas (previously called lethal midline out mice have a very low expression of the apTCR," the granuloma) have been commonly r e p~r t e d~.~.~~,~~ as CD56 absence of CD34 might be responsible for the undetectable positive tumors. We and others have shown that this clinicoexpression of a m C R in these lymphomas. The loss of TCR pathologic entity is associated with Epstein Barr virus infection of lymphoma ~e l l s .~~~~
The non-nasal CD56+ lymphomas have an unusual extranodal initial involvement of the skin, liver, spleen, bone marrow, and central nervous system.z8 It has been reported that NK cell lymphomas have an aggressive clinical c o~r s e .~ This is in agreement with the findings in the present series, as 13 of the 16 patients died within 2 years. However, the prognosis of NK cell lymphomas is difficult to assess because of the heterogeneity of treatment.
expression is comparable to the-loss of other T-cell markers expression, which is of great interest for the immunohistochemical diagnosis of T-cell lymphoma^.^'
Only one of the CD5+ lymphomas was CD56 positive. This case, which had a Leu4/CD3+ helper T-cell phenotype, had clonal rearrangement and can also be regarded as a true PTCL. Two other cases of CDY CD56+ PTCL have been previously reported.'^^' Both were also probably true PTCL, as they were also Leu4/CD3+ and CD4+. Because a minority For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From of peripheral blood T lymphocytes express CD56,32 the CD5+ CD56' lymphomas could be the neoplastic counterpart of these T cells.
Among the four CD5-CD56-lymphomas, two were intestinal lymphomas, one of which was Hh4LKD107' and the other TIA-l+. Both had clonal rearrangements of the TCR y genes and were regarded as true T-cell lymphomas. PCR showed no clonal rearrangement of the TCR y and Ig heavy chain genes in the two other lymphomas. According to Sanchez et al , ' the subpopulation of CD5-CD56-CD3-CD4-CD8-thymocytes contains progenitors of both T and NK lineage. Therefore, these two latter lymphomas might be tumors of T/NK cell progenitors.
This study reports genotypic and extensive immunopheno- For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From
